🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A clinical study to determine the safety, efficacy and the way sitagliptin ...
Status
Completed
Location
Multiple Locations
Start Date
2007-02-14
Trial ID
NCT00704132
Treatments Being Tested
This study will examine the safety and efficacy of the addition of sitaglip...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-15
Trial ID
NCT00885352
Treatments Being Tested
This study will test the effectiveness and safety of treatment with MK-0893...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00631488
Treatments Being Tested
This is a Phase I, first-in-human, randomised, double-blinded, placebo-and ...
Status
Unknown
Location
Parexel International GmbH Early Phase Clinical Unit Klinikum Westend
Start Date
2021-07-07
Trial ID
NCT04982705
The purpose of this study is to evaluate the efficacy and safety of sitagli...
Status
Completed
Location
Multiple Locations
Start Date
2008-01-15
Trial ID
NCT00541450
Sitagliptin, through its effects on sensitizing alpha-cell sensitivity to g...
Status
Completed
Location
Profil Institut für Stoffwechselforschung GmbH
Start Date
2018-03-21
Trial ID
NCT03359590
Treatments Being Tested
This study will determine the effect of concomitant administration of sitag...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT00975052
This study will evaluate the efficacy and safety of 100 mg DRBP108 tablets ...
Status
Completed
Location
Peking University First Hospital
Start Date
2020-01-02
Trial ID
NCT04161430
The purpose of this study is to test the safety and effectiveness of sitagl...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00541775
Treatments Being Tested
The purpose of the study is to assess the effect of the addition of sitagli...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-20
Trial ID
NCT02532855